Protective Effects of Hydrogen Gas on Experimental Acute Pancreatitis.
Hao-Xin Zhou, Bing Han, Li-Min Hou, Ting-Ting An, Guang Jia, Zhuo-Xin Cheng, Yong Ma, Yi-Nan Zhou, Rui Kong, Shuang-Jia Wang, Yong-Wei Wang, Xue-Jun Sun, Shang-Ha Pan, Bei Sun · PloS one · 2016
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In male Wistar rats, the serum levels of TNF-α, IL-1β, and IL-6 were significantly increased 12 h after the onset of AP ( Fig 3A ), and the H₂ treatment significantly reduced these levels. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in male Wistar rats. The serum levels of TNF-α, IL-1β, and IL-6 were significantly increased 12 h after the onset of AP ( Fig 3A ), and the H₂ treatment significantly reduced these levels.
What the Researchers Studied
The researchers studied male Wistar rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 2% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 2% source-reported H₂ gas concentration; 1 L/min H₂ flow (1000 mL/min H₂). The serum levels of TNF-α, IL-1β, and IL-6 were significantly increased 12 h after the onset of AP ( Fig 3A ), and the H₂ treatment significantly reduced these levels. The authors concluded that the results obtained indicate that this gas may represent a novel therapy agent in the management of AP. Molecular hydrogen (H₂) is a potent free radical scavenger that not only ameliorates oxidative stress but also lowers cytokine levels.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was male Wistar rats. The study used a preclinical animal experiment. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 2% source-reported H₂ gas concentration.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.